Clinical trial
Efficacy of Ivermectin in COVID-19 : A Randomized Controlled Trial
NCT04392713 is registered in ClinicalTrials.gov with Combined Military Hospital, Pakistan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Ivermectin in COVID-19 : A Randomized Controlled Trial
- Lead sponsor
- Combined Military Hospital, Pakistan
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 15, 2020
- Completion date
- July 31, 2020
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid